Autologous stem cell transplantation in patients who object to a blood transfusion: contribution of new pharmacological haematopoiesis support. (otvara se novi prozor)

Al-Nawakil C, Quarre MC, Heshmati F, Deau B, Park S, Dreyfus F, Bouscary D, Tamburini J.

Izvor‎: Br J Haematol 2013;161(5):738-40.

Indeks‎: PubMed 23480574

DOI‎: 10.1111/bjh.12284

https://www.ncbi.nlm.nih.gov/pubmed/23480574 (otvara se novi prozor)

Autologous stem-cell transplantation can be performed safely without the use of blood-product support. (otvara se novi prozor)

Ballen KK, Becker PS, Yeap BY, Matthews B, Henry DH, Ford PA.

Izvor‎: J Clin Oncol 2004;22(20):4087-94.

Indeks‎: PubMed 15353543

DOI‎: 10.1200/JCO.2004.01.144

https://www.ncbi.nlm.nih.gov/pubmed/15353543 (otvara se novi prozor)

Safety of bloodless autologous stem cell transplantation in Jehovah's Witness patients. (otvara se novi prozor)

Beck A, Lin R, Reza Rejali A, Rubens M, Paquette R, Vescio R, Merin N, Guerrero M, Federizo Y, Lua M, Uy L, Hernandez L, Allred M, Legaspi R, Leaverton M, Oliva S, Castillo R, Dean L, Bourke J, Cooper S, Gharapetian S, Causin J, Lopiccolo C, Ann Snoussi L, VanStrien P, Lill M, Linhares YP

Izvor‎: Bone Marrow Transplant 2020;55(6):1059-67.

Indeks‎: PubMed 31898692

DOI‎: 10.1038/s41409-019-0777-9

https://www.ncbi.nlm.nih.gov/pubmed/31898692 (otvara se novi prozor)

The use of blood conservation methods in addition to erythropoietin allows myeloablative allogeneic stem cell transplantation without the use of blood products. (otvara se novi prozor)

Ciurea S, Beri R, Dobogai L, Chunduri S, Mahmud N, Rondelli D, Peace D.

Izvor‎: Bone Marrow Transplant 2006;37(3):325-7.

Indeks‎: PubMed 16314850

DOI‎: 10.1038/sj.bmt.1705223

https://www.ncbi.nlm.nih.gov/pubmed/16314850 (otvara se novi prozor)

Hematopoietic stem cell transplantation without the use of blood components by the patient's choice: experience of 2 Brazilian centers. (otvara se novi prozor)

da Silva RL, da Silva LAM, Geraldo BLDSS, Simões AA, Almeida MSS, Fernandes PA, Simões CM, Russo FT, Okada LY, Cavalcante JN, Lopes MAVF, Macedo RA, Macedo MCMA

Izvor‎: Biol Blood Marrow Transplant 2020;26(3):458-62.

Indeks‎: PubMed 31669397

DOI‎: 10.1016/j.bbmt.2019.10.018

https://www.ncbi.nlm.nih.gov/pubmed/31669397 (otvara se novi prozor)

Transfusion challenges in hematology oncology and hematopoietic stem cell transplant - literature review and local experience. (otvara se novi prozor)

Elemary M, Seghatchian J, Stakiw J, Bosch M, Sabry W, Goubran H

Izvor‎: Transfus Apher Sci 2017;56(3):317-21.

Indeks‎: PubMed 28642120

DOI‎: 10.1016/j.transci.2017.05.022

https://www.ncbi.nlm.nih.gov/pubmed/28642120 (otvara se novi prozor)

Autologous stem-cell transplantation without hematopoietic support for the treatment of hematologic malignancies in Jehovah's Witnesses. (otvara se novi prozor)

Ford PA, Grant SJ, Mick R, Keck G.

Izvor‎: J Clin Oncol 2015;33(15):1674-9.

Indeks‎: PubMed 25870085

DOI‎: 10.1200/JCO.2014.57.9912

https://www.ncbi.nlm.nih.gov/pubmed/25870085 (otvara se novi prozor)

Myeloablative chemotherapy and autologous stem cell transplantation without the use of blood products. (otvara se novi prozor)

Jamal F, Lim SW, Vescio R, Pepkowitz S, Van Strien P, Hoshal K, Lill MC.

Izvor‎: Biol Blood Marrow Transplant 2005;11(2 Suppl 1):66-7.

DOI‎: 10.1016/j.bbmt.2004.12.199

http://www.bbmt.org/article/S1083-8791(04)00851-1/fulltext (otvara se novi prozor)

Safety and survival outcomes for bloodless transplantation in patients with myeloma. (otvara se novi prozor)

Joseph NS, Kaufman JL, Boise LH, Valla K, Almaula DK, Obidike CO, Langston AA, Waller EK, Khoury HJ, Flowers CR, Graiser M, Heffner LT, Lonial S, Nooka AK

Izvor‎: Cancer 2019;125(2):185-93.

Indeks‎: PubMed 30480777

DOI‎: 10.1002/cncr.31677

https://www.ncbi.nlm.nih.gov/pubmed/30480777 (otvara se novi prozor)

Bloodless tandem autologous transplant in Jehovah's Witness patients. (otvara se novi prozor)

Khan R, Mott SL, Schultz A, Jethava YS, Tricot G

Izvor‎: Bone Marrow Transplant 2018. [Epub ahead of print]

Indeks‎: PubMed 29795417

DOI‎: 10.1038/s41409-018-0132-6

https://www.ncbi.nlm.nih.gov/pubmed/29795417 (otvara se novi prozor)

Myeloablative therapy and bone marrow transplantation in Jehovah's Witnesses with malignancies: single center experience. (otvara se novi prozor)

Mazza P, Prudenzano A, Amurri B, Palazzo G, Pisapia G, Stani L, Pricolo G.

Izvor‎: Bone Marrow Transplant 2003;32(4):433-6.

Indeks‎: PubMed 12900781

DOI‎: 10.1038/sj.bmt.1704179

https://www.ncbi.nlm.nih.gov/pubmed/12900781 (otvara se novi prozor)

Bloodless (transfusion-free) hematopoietic stem cell transplants: the Mexican experience. (otvara se novi prozor)

Ruiz-Argüelles GJ, Morales-Toquero A, López-Martínez B, Tarín-Arzaga LD, Manzano C.

Izvor‎: Bone Marrow Transplant 2005;36(8):715-20.

Indeks‎: PubMed 16113672

DOI‎: 10.1038/sj.bmt.1705126

https://www.ncbi.nlm.nih.gov/pubmed/16113672 (otvara se novi prozor)

SCT in Jehovah's Witnesses: the bloodless transplant. (otvara se novi prozor)

Sloan JM, Ballen K.

Izvor‎: Bone Marrow Transplant 2008;41(10):837-44.

Indeks‎: PubMed 18246110

DOI‎: 10.1038/bmt.2008.5

https://www.ncbi.nlm.nih.gov/pubmed/18246110 (otvara se novi prozor)